Suppr超能文献

用于脑实质内给药的微制造导管的体内性能

In vivo performance of a microfabricated catheter for intraparenchymal delivery.

作者信息

Brady Martin L, Raghavan Raghu, Singh Deep, Anand P J, Fleisher Adam S, Mata Jaime, Broaddus William C, Olbricht William L

机构信息

Therataxis, LLC, Baltimore, MD, United States.

Therataxis, LLC, Baltimore, MD, United States.

出版信息

J Neurosci Methods. 2014 May 30;229:76-83. doi: 10.1016/j.jneumeth.2014.03.016. Epub 2014 Apr 18.

Abstract

BACKGROUND

Convection-enhanced delivery (CED) is currently the only effective clinical technique to deliver biological therapeutic agents that would otherwise not cross the blood-brain barrier. Despite the promise of CED, several technical problems have limited its effectiveness.

NEW METHOD

Brain infusions into a large mammal (pig) were performed with a catheter that was fabricated using micro-electro-mechanical systems (MEMS) technology (Olbricht et al., 2010). The performance of the catheter was evaluated for infusions at increasing infusion rates. Magnetic resonance (MR) images were acquired in real time to examine the distribution of infused tracers in the parenchyma.

RESULTS

Both backflow and the distribution of CED of infusates into a variety of cytoarchitectures in porcine brain were quantified. Concentration profiles were determined for several MR contrast reagents as well as a fluorescent dye that are the sizes of small molecules, therapeutic proteins and an adeno-associated virus (AAV). The reagents can serve as surrogates for assessing the convective distribution of active molecules. Infusion rates up to 20μL/min were attained without evidence of backflow along the catheter.

COMPARISON WITH EXISTING METHODS

The device performed well in terms of both backflow and infusion, superior to that of many studies reported in the literature on other catheters. All infused molecules had comparable ratios of distribution to infusion volumes.

CONCLUSIONS

The catheter described in this report appears able to target tissue structures with precision, deliver therapeutics at high infusion rates, and resist backflow that can compromise the efficacy of CED therapy. The technology allows development of "smart" catheters for future applications.

摘要

背景

对流增强递送(CED)是目前唯一能够递送无法穿过血脑屏障的生物治疗剂的有效临床技术。尽管CED前景广阔,但一些技术问题限制了其有效性。

新方法

使用微机电系统(MEMS)技术制造的导管对大型哺乳动物(猪)进行脑内输注(Olbricht等人,2010年)。评估了该导管在递增输注速率下的输注性能。实时采集磁共振(MR)图像以检查输注示踪剂在脑实质中的分布。

结果

对猪脑中输注液的回流以及向各种细胞结构的CED分布进行了量化。确定了几种MR造影剂以及一种荧光染料的浓度分布,这些造影剂和染料的大小分别与小分子、治疗性蛋白质和腺相关病毒(AAV)相当。这些试剂可作为评估活性分子对流分布的替代物。在没有沿导管出现回流迹象的情况下实现了高达20μL/分钟的输注速率。

与现有方法的比较

该装置在回流和输注方面均表现良好,优于文献中报道的许多关于其他导管的研究。所有输注的分子在分布与输注体积的比例方面具有可比性。

结论

本报告中描述的导管似乎能够精确靶向组织结构,以高输注速率递送治疗剂,并抵抗可能损害CED治疗效果的回流。该技术允许开发用于未来应用的“智能”导管。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验